The November 2011 edition of AEFJN's Forum for Action is now online. It contains articles on the ethical responsibility of the Church on the climate issue, on the clean up of the Ogoniland oil spills, which will take decades, on the spread of Libyan arms in the Sahel, on the production of medicines in Africa and on the EU's attempt to force African countries to sign EPAs.
The national election campaign officially started the 28th October in the Democratic Republic of Congo (DRC), exactly one month ahead of historic presidential and legislative elections, scheduled for November 28 2011. 41 humanitarian and human rights organizations, among them AEFJN, have expressed concern about the high political tension and deteriorating security situation. They have called upon all Congolese and international actors involved to take urgent measures to prevent electoral violence, better protect civilians and ensure credible, free and fair elections.
Health & Access to Quality Medicines - September 2010
|
|
ACTA and access to generic medicines |
|
 |
The Anti-counterfeiting Trade Agreement (ACTA), proposes a strengthening of intellectual property protections (IPRs) on behalf of multinational drug companies. This, combined with border measures will stifle the trade in legitimate generic medicines and will have a devastating impact on access to medicines in developing countries. The result will be that poor people will be denied legitimate and life-saving generic medicines. |
Addressing Counterfeits without Endangering Public Health |
|
 |
The actual root of the counterfeit medicines problem is grounded in issues of public health, safety and quality. This is where the attention should be focused: to fix the reality of substandard and adulterated medicines. However, rather than developing the solution from a public health and regulatory angle, countries are using an ‘IP enforcement’ approach. |
Tougher intellectual property rules may harm trade in medicines |
|
 |
Free Trade Agreements could harm India's generic drug business, which supplies the bulk of the AIDS medicines sent to developing countries. India's generics could cost more and be harder to access if the country has to adhere to stricter intellectual property rules. |
The role of Indian generic manufacturers in supplying antiretroviral medicines |
|
 |
Indian manufacturers of generic antiretroviral (ARV) medicines facilitated the rapid scale up of HIV/AIDS treatment in developing countries though provision of low-priced, quality-assured medicines. |
Religious leaders commit to action on HIV/AIDS |
|
 |
In the middle of thousands of AIDS researchers and activists from around the world, religious leaders have reaffirmed their pledge to fight stigma and discrimination, promote effective prevention and insure quality treatment and care for those living with HIV and AIDS. |
English - Français
- EN
- FR
Latest News
29.03.2012 13:02 by Administrator AEFJN (comments: 0)
Forum for Action No. 58 online
14.03.2012 16:43 by Administrator AEFJN (comments: 0)
AEFJN News No. 57 online
17.02.2012 09:54 by Administrator AEFJN (comments: 0)
AEFJN News No. 56 online
05.12.2011 15:44 by Administrator AEFJN (comments: 2)
Forum for Action No. 57 online
28.10.2011 06:27 by Begoña Iñarra (comments: 0)
DR Congo Electoral campaign : Call for Urgent measures to Prevent Escalating Violence
Read more … DR Congo Electoral campaign : Call for Urgent measures to Prevent Escalating Violence